Skip to content

Aviva shares up on £300m buy-back

Insurer unveils a solid set of full-year results as Cevian cuts holding

Aviva shares up on share buy-back Source: Bloomberg

Aviva PLC posted upbeat full-year results as activist investor Cevian took a back seat at the company. The activist investor had cut its shareholding in the insurer to less than 5% prior to the company announcing it would return more cash to investors. Cevian had pushed for Aviva to return more capital to investors.

The insurer unveiled a share buyback scheme of £300 million alongside its results. Aviva has returned £5 billion to shareholders since 2021. Shares in the company rose 3% to 463.5p on Thursday.

Operating profits for the full-year 2022 rose by 35% to £2.2 billion, while general insurance gross premiums increased by 8% to £9.7 billion. The Solvency II cover ratio, which rates the insurer’s financial health and ability to meet liabilities, came in at a healthy 212%, albeit down from 244% in the same period last year. UK and Ireland value of new business increased by 15% to £767 million.

Aviva – strong trading momentum

"We are making excellent progress at Aviva,” chief executive Amanda Blanc told investors. “Operating profits and dividends are growing and we have strong trading momentum despite significant market volatility.

“Our core businesses in the UK, Ireland and Canada grew in 2022, and contributed to a very strong, all round performance. Life insurance value of new business is up 15%, general insurance sales are up 8% and overall operating profit is up 35%.”

Blanc says that cash remittances are “up strongly” – they rose 11% to £1.8 billion during the period – and that the insurer’s capital position is “robust,” while customer numbers have increased to 15.5 million.

The company saw net inflows of £9.1 billion in its wealth division during the year, boosted by a strong performance in Workplace, which added 374 additional schemes.

However, annuities and equity release sales fell by 21% to £6.2 billion. UK and Ireland general insurance gross written premiums rose by 7% to £5.7 billion.

Aviva – bullish on outlook

Despite the difficult macroeconomic environment, the insurer says it expects to see continuing strength in its commercial line of general insurance and higher bulk purchase annuities in UK and Ireland life insurance as pension companies de-risk.

The company is also focusing on efficiencies and is on track to make £750 million in cost cuts so far this year.

Meanwhile, Aviva is looking to increase its dividend pay-out policy to the low to mid-single digit levels, with a pay-out of £915 million due for 2023.

Analysts at UBS set a price target of 505p on the shares, while those at Barclays think the shares could reach 560p.

Shares in the insurer are up 12% over the past 12 months to 450p. However, with a 9% dividend yield and solid growth prospects, they are a buy.

Take your position on 17,000+ shares with the UK’s No.1 platform.* Learn more about trading or investing in shares with us, or open an account to get started today.
* Best trading platform as awarded at the ADVFN International Financial Awards 2022

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.